Fiber-Reinforced Kneebar for Bone Marrow Edema
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must not have had a steroid injection or any other non-surgical intervention in the study knee for at least 3 months before joining the trial.
What data supports the effectiveness of the Fiber-Reinforced Kneebar treatment OSSIOfiber® Trimmable Fixation Nails for Bone Marrow Edema?
The research on intramedullary nails, like the Fixion nail, shows that these types of treatments can stabilize fractures effectively, allowing for partial weight-bearing in about a week and full weight-bearing in about 40 days. This suggests that similar stabilization techniques, like the OSSIOfiber® nails, could be effective in treating bone conditions such as bone marrow edema.12345
Is the Fiber-Reinforced Kneebar for Bone Marrow Edema safe for humans?
How is the OSSIOfiber® Trimmable Fixation Nails treatment unique for bone marrow edema?
The OSSIOfiber® Trimmable Fixation Nails are unique because they are made from a bio-integrative, fiber-reinforced material that allows for complete absorption and integration into the bone over time, unlike traditional metal implants that remain in the body. This technology reduces the need for implant removal surgery and minimizes the risk of adverse tissue reactions.367811
What is the purpose of this trial?
The OSSIOfiber® Trimmable Fixation Nails are indicated for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts in the presence of appropriate additional immobilization (e.g., rigid fixation implants, cast, brace). Our hypothesis is that the use of OSSIOfiber® Trimmable Fixation Nails for treating subchondral insufficiency of the knee will result in improvement of patient-reported outcomes and imaging findings. The primary objective of this study is to evaluate the effectiveness of implanting bio-integrative OSSIOfiber® Trimmable Fixation Nails, organized in a bi-cortical rafter formation within the tibia or femur for the management of subchondral insufficiency. The OSSIOfiber® Trimmable Fixation Nails used in this study will be considered on-label.
Eligibility Criteria
This trial is for adults aged 18-75 with a BMI under 40, experiencing knee pain due to conditions like meniscal tears or osteoarthritis. Participants must have confirmed bone marrow lesions in the knee and not received steroid injections for at least 3 months. They should be able to attend follow-up visits and complete questionnaires.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Implantation of bio-integrative OSSIOfiber® Trimmable Fixation Nails for the management of subchondral insufficiency
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of KOOS and other outcome measures
Treatment Details
Interventions
- OSSIOfiber® Trimmable Fixation Nails
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor